Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Neuro Omega System, NeuroSmart System

K-Number: K220553 · 2022-09-16

Decision Date2022-09-16
Product CodeGZL
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

Neuro Omega System, NeuroSmart System is a medical device manufactured by Alpha Omega Engineering , Ltd.. It received FDA 510(k) clearance on 2022-09-16 under approval number K220553. The device is classified under product code GZL. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Neuro Omega System, NeuroSmart System?

Neuro Omega System, NeuroSmart System is a medical device that received FDA 510(k) clearance on 2022-09-16. It is manufactured by Alpha Omega Engineering , Ltd.. The 510(k) number is K220553.

When was Neuro Omega System, NeuroSmart System approved by the FDA?

Neuro Omega System, NeuroSmart System received FDA 510(k) clearance on 2022-09-16, under approval number K220553.

What company makes Neuro Omega System, NeuroSmart System?

Neuro Omega System, NeuroSmart System is manufactured by Alpha Omega Engineering , Ltd..

What is the FDA product code for Neuro Omega System, NeuroSmart System?

The FDA product code for Neuro Omega System, NeuroSmart System is GZL.

Related Clinical Trials

Other Devices by Alpha Omega Engineering , Ltd.

Related Devices (Code: GZL)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.